1. Home
  2. QNCX vs LICN Comparison

QNCX vs LICN Comparison

Compare QNCX & LICN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNCX
  • LICN
  • Stock Information
  • Founded
  • QNCX 2012
  • LICN 2004
  • Country
  • QNCX United States
  • LICN China
  • Employees
  • QNCX N/A
  • LICN N/A
  • Industry
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • LICN
  • Sector
  • QNCX Health Care
  • LICN
  • Exchange
  • QNCX Nasdaq
  • LICN Nasdaq
  • Market Cap
  • QNCX 47.7M
  • LICN 3.1M
  • IPO Year
  • QNCX 2019
  • LICN 2023
  • Fundamental
  • Price
  • QNCX $2.00
  • LICN $4.44
  • Analyst Decision
  • QNCX Strong Buy
  • LICN
  • Analyst Count
  • QNCX 5
  • LICN 0
  • Target Price
  • QNCX $8.00
  • LICN N/A
  • AVG Volume (30 Days)
  • QNCX 374.6K
  • LICN 24.5K
  • Earning Date
  • QNCX 08-12-2025
  • LICN 01-01-0001
  • Dividend Yield
  • QNCX N/A
  • LICN N/A
  • EPS Growth
  • QNCX N/A
  • LICN N/A
  • EPS
  • QNCX N/A
  • LICN N/A
  • Revenue
  • QNCX N/A
  • LICN $41,477,000.00
  • Revenue This Year
  • QNCX N/A
  • LICN N/A
  • Revenue Next Year
  • QNCX N/A
  • LICN N/A
  • P/E Ratio
  • QNCX N/A
  • LICN N/A
  • Revenue Growth
  • QNCX N/A
  • LICN 4.32
  • 52 Week Low
  • QNCX $0.51
  • LICN $2.60
  • 52 Week High
  • QNCX $2.45
  • LICN $488.00
  • Technical
  • Relative Strength Index (RSI)
  • QNCX 70.90
  • LICN 53.94
  • Support Level
  • QNCX $1.55
  • LICN $4.02
  • Resistance Level
  • QNCX $1.71
  • LICN $4.41
  • Average True Range (ATR)
  • QNCX 0.15
  • LICN 0.25
  • MACD
  • QNCX 0.02
  • LICN 0.05
  • Stochastic Oscillator
  • QNCX 89.09
  • LICN 92.57

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

About LICN Lichen China Limited

Lichen International Ltd is a financial and taxation service provider in China. The company provides financial and taxation solution services; education support services; and software and maintenance services in the PRC under its Lichen brand. The financial and taxation solution services comprise financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation. The education support services comprise the provision of marketing, operational and technical support and the sales of teaching and learning materials. The software and maintenance services comprise the sales of financial and taxation analysis software and sales of financial and taxation training software.

Share on Social Networks: